Tesla stock had an extraordinary run in the last month. Click here to find out why we continue to believe that TSLA stock is ...

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Read here for more on SMCI stock's struggles with equity or debt options, removal from index, reporting delays, and negative ...

Panagram AAA CLO ETF invests in AAA CLOs and comes from Panagram Structured Asset Management. Click here to read more about ...

Paycor HCM's new guidance indicates sustainable mid-teens recurring revenue growth. Click here to read why I've upgraded PYCR ...

Fox Factory's Q3 2024 revenue missed expectations due to macroeconomic conditions and reduced OEM forecasts. Read why FOXF ...

The January effect, initially observed in small-cap stocks, has diminished over time, likely due to randomness rather than a ...

Treasury Inflation-Protected Securities offer a great risk-reward outlook, with PIMCO 15+ Year U.S. TIPS Index ...

T. Rowe Price Ultra Short-Term Bond ETF has a 5.3% yield with low volatility and alternative options for minimal ...

We caution investors on Vistra, highlighting overvaluation despite growth and green initiatives. See why we suggest a hold on ...

We recommend holding Adobe stock, with a potential buy opportunity at $350, citing strong cash flow and AI potential. Read an ...

Mastercard is a solid long-term investment with strong growth prospects, driven by its global reach and innovative business ...